Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · page 21 of 50
The chart uses a regression line to correlate human and NHP half-lives, highlighting the 3.1x multiplier for YTE-modified antibodies.
Deck · other · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 list 1/1 source-note 1/1 title 1/1
Components 5
primary scatter bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.